← DXCM Overview
8-KFebruary 26, 20262/26/26
DXCM — 8-K Filing
Track for AlertsDXCM 8-K Summary
On February 26, 2026, DEXCOM INC filed an 8-K covering 3 items, including Departure / Election of Directors or Officers (Item 5.02), Financial Statements and Exhibits (Item 9.01), and 1 additional item. Primary disclosure: DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS.On February 26, 2026, the Board of Directors (the “Board”) of DexCom, Inc.
8-K Items Disclosed
Item 5.02 — Departure / Election of Directors or Officers
Officer or director change — appointment, resignation, retirement, or termination, plus compensation arrangements.
DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS.On February 26, 2026, the Board of Directors (the “Board”) of DexCom, Inc. (“Dexcom” or the “Company”), pursuant to the Amended and Restated Bylaws of the Company, increased the size of the Board to twelve directors and appointed Albert F. (“Rick”) Osterloh, IV as a director effective immediately. Mr. Osterloh will hold office for a term expiring at the 2026 annual meeting of Dexcom’s stockholders (the “2026 Annual Meeting”). The Board also appointed Mr.
Item 7.01 — Regulation FD Disclosure
Voluntarily-disclosed material information under Regulation FD (e.g., investor presentation, conference talk).
On February 26, 2026, Dexcom announced the appointment of Mr. Osterloh to the Board in a press release furnished as Exhibit 99.1 to this report and is incorporated herein by this reference.
Item 9.01 — Financial Statements and Exhibits
Press releases, exhibits, and supporting documents attached to this filing.
(d) Exhibits.NumberDescription99.1Press release dated February 26, 2026104Cover Page Interactive Data File (formatted as Inline XBRL)SIGNATURESPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.DEXCOM, INC.By: /s/ JEREME M. SYLVAINJereme M. SylvainExecutive Vice President, Chief Financial OfficerDate:February 26, 2026
Structured financials are not available for this filing. View the original on SEC EDGAR for details.
Current DredgeCap Risk Profile
3.2/10
MODERATE RISK
Dilution Risk
LOW2.5/10
Liquidity Risk
LOW2.0/10
Debt Toxicity
MODERATE3.5/10
Profitability Risk
LOW2.8/10
Going Concern✓ Not flagged
The risk profile above reflects the latest cached DredgeCap analysis for DXCM. For the full filing-by-filing analyst report (red flags, primary risk driver, what moves the stock), open DXCM's company page.
What is a 8-K?
A current report disclosing a material event that occurred between regular reporting periods. Companies are required to file an 8-K within four business days of certain events including earnings releases, executive changes, acquisitions, debt obligations, restructurings, and material agreements. Each 8-K specifies one or more 'Items' identifying which event triggered the filing.
Form-type explainers and 8-K item descriptions are derived from SEC documentation. Financial values are extracted from SEC-tagged XBRL — see the "Source filings" list above each table for direct EDGAR links to every cited filing. This page does not constitute investment advice. Always consult the original filing on SEC EDGAR for authoritative content, and consult a licensed financial advisor for investment decisions.